Venus MedTech

#Transcatheter Heart Valves #TAVR #Structural Heart Disease #Cardiovascular Devices

Venus MedTech (HKEX: 2500) is a leading Chinese structural heart company developing transcatheter heart valve technologies. Its product portfolio includes VenusP-Valve (transcatheter pulmonary valve), Venus-A (TAVR), and the Venus-PowerX system (first fully recoverable self-expanding dry-valve TAVR).

Company Info

Sector:Cardiovascular Medical Devices / Structural Heart

Headquarters:Hangzhou, China

Founded:2009

Website:www.venusmedtech.com/

Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-PowerX, the World's First Fully Recoverable Self-Expanding Dry-Valve TAVR System ↗

Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-PowerX, the World's First Fully Recoverable Self-Expanding Dry-Valve TAVR System.

Leadership Team

Careers & Job Openings

See all open roles

Multiple Departments

China - Hangzhou

Apply Now →